<?xml version="1.0" encoding="UTF-8"?>
<ref id="B116-pharmaceuticals-13-00283">
 <label>116.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ezhevsky</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Nagahara</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Vocero-Akbani</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Gius</surname>
    <given-names>D.R.</given-names>
   </name>
   <name>
    <surname>Wei</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Dowdy</surname>
    <given-names>S.F.</given-names>
   </name>
  </person-group>
  <article-title>Hypo-phophorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>1997</year>
  <volume>94</volume>
  <fpage>10699</fpage>
  <lpage>10704</lpage>
  <pub-id pub-id-type="pmid">9380698</pub-id>
 </element-citation>
</ref>
